Tatsuya Toyama

9PUBLICATIONS
37CO-AUTHORS
Organisational, interpersonal and intercultural communicationPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Communication technology and digital media studiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 31, 2026
Social Media Discourse on Breast Cancer Screening Barriers in Japanese and English: Cross-Sectional Infodemiology Study.

|Nov 04, 2025
HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy.

Kazuki Nozawa, Masataka Sawaki, Yukari Uemura

|May 24, 2025
Optimal patient population for adjuvant S-1 therapy in hormone receptor-positive, HER2-negative early breast cancer.

Ayaka Isogai, Mitsuo Terada, Yumi Wanifuchi-Endo

|Sep 06, 2023
Fact-Checking Cancer Information on Social Media in Japan: Retrospective Study Using Twitter.

Nari Kureyama, Mitsuo Terada, Maho Kusudo

|Dec 18, 2022
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer.

Kiyoshi Minohara, Masaki Imai, Takuma Matoba

|Aug 08, 2022
Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study.

Mitsuo Terada, Naoto Kondo, Yumi Wanifuchi-Endo

Pageof 2

Frequent Collaborators

3 joint publications

Tomoko Asano

3 joint publications

Yumi Wanifuchi-Endo

3 joint publications

Kazuki Nozawa

3 joint publications

Mitsuo Terada